Report Detail

Medical Devices & Consumables Global RNA Interference Technology Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4626738
  • |
  • 10 September, 2025
  • |
  • Global
  • |
  • 118 Pages
  • |
  • GIR
  • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global RNA Interference Technology market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
This report is a detailed and comprehensive analysis for global RNA Interference Technology market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global RNA Interference Technology market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global RNA Interference Technology market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global RNA Interference Technology market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global RNA Interference Technology market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for RNA Interference Technology
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global RNA Interference Technology market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alnylam Pharmaceuticals, Arcturus Therapeutics Holdings, Arrowhead Pharmaceuticals, AstraZeneca, Atalanta Therapeutics, Bioneer Corporation, CureVac N.V., Dicerna Pharmaceuticals, Gradalis, Ionis Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
RNA Interference Technology market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
dsRNA
miRNA
Market segment by Application
Drug Discovery and Development
Diagnostic Centers
Others
Major players covered
Alnylam Pharmaceuticals
Arcturus Therapeutics Holdings
Arrowhead Pharmaceuticals
AstraZeneca
Atalanta Therapeutics
Bioneer Corporation
CureVac N.V.
Dicerna Pharmaceuticals
Gradalis
Ionis Pharmaceuticals
Merck KGaA
Nutcracker Therapeutics
Phio Pharmaceuticals
Sirnaomics
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe RNA Interference Technology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of RNA Interference Technology, with price, sales quantity, revenue, and global market share of RNA Interference Technology from 2020 to 2025.
Chapter 3, the RNA Interference Technology competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the RNA Interference Technology breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and RNA Interference Technology market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of RNA Interference Technology.
Chapter 14 and 15, to describe RNA Interference Technology sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global RNA Interference Technology Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 dsRNA
    • 1.3.3 miRNA
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global RNA Interference Technology Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Drug Discovery and Development
    • 1.4.3 Diagnostic Centers
    • 1.4.4 Others
  • 1.5 Global RNA Interference Technology Market Size & Forecast
    • 1.5.1 Global RNA Interference Technology Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global RNA Interference Technology Sales Quantity (2020-2031)
    • 1.5.3 Global RNA Interference Technology Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Alnylam Pharmaceuticals
    • 2.1.1 Alnylam Pharmaceuticals Details
    • 2.1.2 Alnylam Pharmaceuticals Major Business
    • 2.1.3 Alnylam Pharmaceuticals RNA Interference Technology Product and Services
    • 2.1.4 Alnylam Pharmaceuticals RNA Interference Technology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Alnylam Pharmaceuticals Recent Developments/Updates
  • 2.2 Arcturus Therapeutics Holdings
    • 2.2.1 Arcturus Therapeutics Holdings Details
    • 2.2.2 Arcturus Therapeutics Holdings Major Business
    • 2.2.3 Arcturus Therapeutics Holdings RNA Interference Technology Product and Services
    • 2.2.4 Arcturus Therapeutics Holdings RNA Interference Technology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Arcturus Therapeutics Holdings Recent Developments/Updates
  • 2.3 Arrowhead Pharmaceuticals
    • 2.3.1 Arrowhead Pharmaceuticals Details
    • 2.3.2 Arrowhead Pharmaceuticals Major Business
    • 2.3.3 Arrowhead Pharmaceuticals RNA Interference Technology Product and Services
    • 2.3.4 Arrowhead Pharmaceuticals RNA Interference Technology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Arrowhead Pharmaceuticals Recent Developments/Updates
  • 2.4 AstraZeneca
    • 2.4.1 AstraZeneca Details
    • 2.4.2 AstraZeneca Major Business
    • 2.4.3 AstraZeneca RNA Interference Technology Product and Services
    • 2.4.4 AstraZeneca RNA Interference Technology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 AstraZeneca Recent Developments/Updates
  • 2.5 Atalanta Therapeutics
    • 2.5.1 Atalanta Therapeutics Details
    • 2.5.2 Atalanta Therapeutics Major Business
    • 2.5.3 Atalanta Therapeutics RNA Interference Technology Product and Services
    • 2.5.4 Atalanta Therapeutics RNA Interference Technology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Atalanta Therapeutics Recent Developments/Updates
  • 2.6 Bioneer Corporation
    • 2.6.1 Bioneer Corporation Details
    • 2.6.2 Bioneer Corporation Major Business
    • 2.6.3 Bioneer Corporation RNA Interference Technology Product and Services
    • 2.6.4 Bioneer Corporation RNA Interference Technology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Bioneer Corporation Recent Developments/Updates
  • 2.7 CureVac N.V.
    • 2.7.1 CureVac N.V. Details
    • 2.7.2 CureVac N.V. Major Business
    • 2.7.3 CureVac N.V. RNA Interference Technology Product and Services
    • 2.7.4 CureVac N.V. RNA Interference Technology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 CureVac N.V. Recent Developments/Updates
  • 2.8 Dicerna Pharmaceuticals
    • 2.8.1 Dicerna Pharmaceuticals Details
    • 2.8.2 Dicerna Pharmaceuticals Major Business
    • 2.8.3 Dicerna Pharmaceuticals RNA Interference Technology Product and Services
    • 2.8.4 Dicerna Pharmaceuticals RNA Interference Technology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Dicerna Pharmaceuticals Recent Developments/Updates
  • 2.9 Gradalis
    • 2.9.1 Gradalis Details
    • 2.9.2 Gradalis Major Business
    • 2.9.3 Gradalis RNA Interference Technology Product and Services
    • 2.9.4 Gradalis RNA Interference Technology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Gradalis Recent Developments/Updates
  • 2.10 Ionis Pharmaceuticals
    • 2.10.1 Ionis Pharmaceuticals Details
    • 2.10.2 Ionis Pharmaceuticals Major Business
    • 2.10.3 Ionis Pharmaceuticals RNA Interference Technology Product and Services
    • 2.10.4 Ionis Pharmaceuticals RNA Interference Technology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Ionis Pharmaceuticals Recent Developments/Updates
  • 2.11 Merck KGaA
    • 2.11.1 Merck KGaA Details
    • 2.11.2 Merck KGaA Major Business
    • 2.11.3 Merck KGaA RNA Interference Technology Product and Services
    • 2.11.4 Merck KGaA RNA Interference Technology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Merck KGaA Recent Developments/Updates
  • 2.12 Nutcracker Therapeutics
    • 2.12.1 Nutcracker Therapeutics Details
    • 2.12.2 Nutcracker Therapeutics Major Business
    • 2.12.3 Nutcracker Therapeutics RNA Interference Technology Product and Services
    • 2.12.4 Nutcracker Therapeutics RNA Interference Technology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Nutcracker Therapeutics Recent Developments/Updates
  • 2.13 Phio Pharmaceuticals
    • 2.13.1 Phio Pharmaceuticals Details
    • 2.13.2 Phio Pharmaceuticals Major Business
    • 2.13.3 Phio Pharmaceuticals RNA Interference Technology Product and Services
    • 2.13.4 Phio Pharmaceuticals RNA Interference Technology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.13.5 Phio Pharmaceuticals Recent Developments/Updates
  • 2.14 Sirnaomics
    • 2.14.1 Sirnaomics Details
    • 2.14.2 Sirnaomics Major Business
    • 2.14.3 Sirnaomics RNA Interference Technology Product and Services
    • 2.14.4 Sirnaomics RNA Interference Technology Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.14.5 Sirnaomics Recent Developments/Updates

3 Competitive Environment: RNA Interference Technology by Manufacturer

  • 3.1 Global RNA Interference Technology Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global RNA Interference Technology Revenue by Manufacturer (2020-2025)
  • 3.3 Global RNA Interference Technology Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of RNA Interference Technology by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 RNA Interference Technology Manufacturer Market Share in 2024
    • 3.4.3 Top 6 RNA Interference Technology Manufacturer Market Share in 2024
  • 3.5 RNA Interference Technology Market: Overall Company Footprint Analysis
    • 3.5.1 RNA Interference Technology Market: Region Footprint
    • 3.5.2 RNA Interference Technology Market: Company Product Type Footprint
    • 3.5.3 RNA Interference Technology Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global RNA Interference Technology Market Size by Region
    • 4.1.1 Global RNA Interference Technology Sales Quantity by Region (2020-2031)
    • 4.1.2 Global RNA Interference Technology Consumption Value by Region (2020-2031)
    • 4.1.3 Global RNA Interference Technology Average Price by Region (2020-2031)
  • 4.2 North America RNA Interference Technology Consumption Value (2020-2031)
  • 4.3 Europe RNA Interference Technology Consumption Value (2020-2031)
  • 4.4 Asia-Pacific RNA Interference Technology Consumption Value (2020-2031)
  • 4.5 South America RNA Interference Technology Consumption Value (2020-2031)
  • 4.6 Middle East & Africa RNA Interference Technology Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global RNA Interference Technology Sales Quantity by Type (2020-2031)
  • 5.2 Global RNA Interference Technology Consumption Value by Type (2020-2031)
  • 5.3 Global RNA Interference Technology Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global RNA Interference Technology Sales Quantity by Application (2020-2031)
  • 6.2 Global RNA Interference Technology Consumption Value by Application (2020-2031)
  • 6.3 Global RNA Interference Technology Average Price by Application (2020-2031)

7 North America

  • 7.1 North America RNA Interference Technology Sales Quantity by Type (2020-2031)
  • 7.2 North America RNA Interference Technology Sales Quantity by Application (2020-2031)
  • 7.3 North America RNA Interference Technology Market Size by Country
    • 7.3.1 North America RNA Interference Technology Sales Quantity by Country (2020-2031)
    • 7.3.2 North America RNA Interference Technology Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe RNA Interference Technology Sales Quantity by Type (2020-2031)
  • 8.2 Europe RNA Interference Technology Sales Quantity by Application (2020-2031)
  • 8.3 Europe RNA Interference Technology Market Size by Country
    • 8.3.1 Europe RNA Interference Technology Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe RNA Interference Technology Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific RNA Interference Technology Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific RNA Interference Technology Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific RNA Interference Technology Market Size by Region
    • 9.3.1 Asia-Pacific RNA Interference Technology Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific RNA Interference Technology Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America RNA Interference Technology Sales Quantity by Type (2020-2031)
  • 10.2 South America RNA Interference Technology Sales Quantity by Application (2020-2031)
  • 10.3 South America RNA Interference Technology Market Size by Country
    • 10.3.1 South America RNA Interference Technology Sales Quantity by Country (2020-2031)
    • 10.3.2 South America RNA Interference Technology Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa RNA Interference Technology Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa RNA Interference Technology Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa RNA Interference Technology Market Size by Country
    • 11.3.1 Middle East & Africa RNA Interference Technology Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa RNA Interference Technology Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 RNA Interference Technology Market Drivers
  • 12.2 RNA Interference Technology Market Restraints
  • 12.3 RNA Interference Technology Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of RNA Interference Technology and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of RNA Interference Technology
  • 13.3 RNA Interference Technology Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 RNA Interference Technology Typical Distributors
  • 14.3 RNA Interference Technology Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on RNA Interference Technology. Industry analysis & Market Report on RNA Interference Technology is a syndicated market report, published as Global RNA Interference Technology Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of RNA Interference Technology market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report